Barely Significant
← all excerpts

Clinically significant sub-clonality for common drivers can be detected in 26% of KRAS/EGFR mutated lung adenocarcinomas.

Oncotarget · 2017 · PMC5542222 · PMID 28501852

Europe PMCDOI
1
hedged sentence
0.1000
closest p · 2.0× alpha
0.1000
boldest claim

The sentences

showed a trendp=0.1so close (0.05 < p ≤ 0.1)
Surprisingly, sub-clonality for EGFR mutation was associated with shorter survival time (p=0.03, Figure 3B ) whereas sub-clonality for KRAS mutation only showed a trend toward shorter survival time (p=0.1, Figure 3A ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.